Form 4: VolitionRx Chief Medical Officer Receives Stock Award in Lieu of Cash Compensation

Andrew Retter, Chief Medical Officer of VolitionRx Ltd, received 8,326 restricted stock units (RSUs) on June 1, 2024, in lieu of cash compensation.

Summary

• On June 4, 2024, Andrew Retter, the Chief Medical Officer of VolitionRx Ltd, filed a Form 4 with the SEC.
• The filing reports that on June 1, 2024, Retter was awarded 8,326 restricted stock units (RSUs) under the company's 2015 Stock Incentive Plan.
• These RSUs were granted in lieu of cash compensation that would have otherwise been owed to Retter.
• The RSUs vest in three installments: 2,776 units on June 1, 2024, 2,775 units on July 1, 2024, and 2,775 units on August 1, 2024.
• The RSUs are also subject to further time-based vesting in a single installment on May 1, 2025, and are generally subject to continued service throughout each applicable vesting date.
• Upon vesting and settlement, Retter will receive shares of common stock equal to the number of RSUs that have vested.
• Following the transaction, Retter beneficially owns 108,326 shares of VolitionRx Ltd.
• The filing was signed by Andrew Retter on June 4, 2024.

Sentiment

Score: 6

Explanation: The document is neutral, reporting a standard executive compensation event. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Positives

• The award of RSUs aligns the interests of the Chief Medical Officer with those of the shareholders.
• The vesting schedule incentivizes continued service and contribution to the company.

Industry Context

Stock awards are a common form of compensation for executives in publicly traded companies, aligning their interests with those of shareholders and incentivizing long-term performance.

Comparison to Industry Standards

• Stock-based compensation is a common practice among biotechnology companies to attract and retain key personnel.
• Companies like Exact Sciences and Guardant Health also utilize stock options and RSUs as part of their executive compensation packages.
• The size of the RSU award is likely determined by factors such as the executive's role, performance, and the company's overall compensation strategy.

Stakeholder Impact

• Shareholders may view the stock award as a positive sign, aligning management's interests with the company's long-term success.
• Employees may see the stock award as a sign of the company's commitment to its leadership team.

Key Dates